Previous article Table of Contents  Next article

CASE REPORT
Year : 2015  |  Volume : 9  |  Issue : 1  |  Page : 91-93

Anesthetic management of patient with systemic lupus erythematosus and antiphospholipid antibodies syndrome for laparoscopic nephrectomy and cholecystectomy


King Saud University/College of Medicine, King Khalid University Hospital, Riyadh, Saudi Arabia

Correspondence Address:
Dr. Rashid Saeed Khokhar
King Saud University/College of Medicine, King Khalid University Hospital, Riyadh
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1658-354X.146325

Rights and Permissions
Date of Web Publication5-Dec-2014
 

  Abstract 

We report a case of a female having systemic lupus erythematosus and antiphospholipid antibodies syndrome, who was on immunosuppressant therapy. We discussed the preoperative evaluation and perioperative management who underwent nephrectomy and cholecystectomy.

Keywords: Anesthetic management, antiphospholipid syndrome, systemic lupus erythematosus


How to cite this article:
Khokhar RS, Baaj J, Al-Saeed A, Sheraz M. Anesthetic management of patient with systemic lupus erythematosus and antiphospholipid antibodies syndrome for laparoscopic nephrectomy and cholecystectomy. Saudi J Anaesth 2015;9:91-3

How to cite this URL:
Khokhar RS, Baaj J, Al-Saeed A, Sheraz M. Anesthetic management of patient with systemic lupus erythematosus and antiphospholipid antibodies syndrome for laparoscopic nephrectomy and cholecystectomy. Saudi J Anaesth [serial online] 2015 [cited 2020 Jun 4];9:91-3. Available from: http://www.saudija.org/text.asp?2015/9/1/91/146325


  Introduction Top


Systemic lupus erythematosus (SLE) is an autoimmune disease with heterogeneous presentation and with systemic involvement in which tissues and multiple organs are damaged by pathogenic autoantibodies and immune complexes. [1] It is characterized by the presence of autoantibodies directed against nuclear antigens. The prevalence of SLE varies with ethnicity, but is estimated to be about 1/1000 overall; with female to male ratio of 10:1, the peak age of onset being between 15 and 40 years. [2],[3],[4]

We need the presence of four of the following to diagnose SLE: Discoid rash, photosensitivity, oral ulcers, arthritis, serositis (pleuritis and pericarditis), renal involvement, neurologic disorder (seizures and psychosis), immunologic disorder (hemolytic anemia, leucopenia, and thrombocytopenia), characteristic facial malar rash, and immunologic disorder. Hypercoagulable state may be present. [3] Antinuclear antibody and anti-double stranded DNA (dsDNA) are positive with very high titers, and serum complement levels (C3, C4) are low. As it is a multisystem disorder, a thorough preanesthetic evaluation is essential for safe anesthesia management. Anesthetic plan must be individualized based on the degree of the involvement of the various systems, current medications the patient is taking, and on the laboratory investigations. [3] We present the perioperative management of a patient with a history of SLE posted for laparoscopic nephrectomy and cholecystectomy.


  Case Report Top


We report a case of a 21-year-old, 70 kg female having SLE and antiphospholipid (APL) syndrome for 2 years, who was scheduled for laparoscopic nephrectomy and cholecystectomy. She was in her usual state of health before 2 years when she developed right superficial femoral and popliteal deep venous thrombosis twice, and she was anticoagulated with warfarin for 2 months. After 3 months, she developed two episodes of left hemiparesis due to right frontal lobe ischemic stroke. Thrombophilic screening done only anticardiolipin antibodies were positive. After 1 year she developed sudden acute chest pain, and cardiac enzymes were mildly elevated. After 3 months of that event she presented in an emergency with epigastric ad right flank pain, ultrasonography abdomen showing right hydronephrosis. Renal function tests were moderately elevated, and emergency right nephrostomy tube was placed. On further evaluation, she diagnosed to have lupus nephritis chronic kidney disease stage 3 and positive APL antibodies and dsDNA antibodies. Right ureteric stricture was present and on dimercaptosuccinic acid cortical scan right kidney function was 20%. Multiple gall bladder stones noticed.

Preoperatively patient is having hypertension, lupus nephritis, APL syndrome, SLE, and perimyocarditis. Laboratory results were within normal limits. Chest X-ray was unremarkable. Electrocardiogram (ECG) showing left ventricular hypertrophy and echocardiogram was normal. She was on low molecular weight heparin, calcium channel blocker, angiotensin converting enzyme inhibitor, azathioprine, hydrocortisone, and opioid analgesics. All medications continued up to day of surgery. After applying all standard monitoring, she induced with good dose opioid, etomidate, and cisatracurium. Difficulty encountered in passing even 7.0 mm endotracheal tube (ETT), so intubated with 6.5 mm ETT, and excessive neck movements were avoided. Radial arterial cannulation done. Foley urinary catheter and orogastric tube placed and patient positioned for surgery. Depth of anesthesia was maintained with sevoflurane and infusions of remifentanil and cisatracurium. Intermittent intravenous boluses of labetalol given to lower the blood pressure. Degree of muscle relaxation monitored by peripheral nerve stimulator and urine output monitored per hour basis. Intraoperative blood loss was 500 ml and urine output was 80 ml/h and 300 ml positive fluid balance. After 3 h of surgery patient extubated and transferred to high dependency unit, postoperative pain managed effectively with morphine patient-controlled analgesia.


  Discussion Top


From our experience and systematic review of the literature [1],[3] suggests that perioperative management must be tailored to the individual patient. Anesthetic management plan was made after taking into account severity of the disease, the potential drug interactions with immunosuppressants, an unexpected difficult airway with subglottic stenosis or laryngeal edema, and coagulation profile of the patient.

Patients with SLE have a variety of abnormalities of varying intensity. Therefore, there are a host of presentations, and the course is highly variable, ranging from relatively mild and uncomplicated to major life-threatening disease. Cardiovascular involvement could be in the form of pericarditis, myocarditis, arthrosclerosis, and the myocardial ischemia. [1] Pulmonary involvement could vary from pleuritis, pleural effusion, alveolar hemorrhage, and interstitial lung disease. [5] Renal involvement is seen in the form of lupus nephritis characterized by proteinuria, hematuria, and abnormal urinary segments. [6] As the present in our case, patients with SLE are at high risk of hypertension renal status. The risk may increase in case the patient requires more than 30 mg of prednisolone daily. [2] Our patient was on high-dose prednisolone and developed hypertension.

A 37-95% of SLE patients may manifest central and peripheral nervous system complications. American College of Rheumatology recommends the term neuropsychiatric SLE to encompass all possible manifestations which may vary from headaches, seizures, cerebrovascular disease, psychosis, acute confusional states to even demyelinating disease states. [3] Our patient suffered twice left hemi paresis and improved by physical rehabilitation. Hematological manifestations commonly seen in SLE include anemia, thrombocytopenia, and leucopenia. Anemia is found in about half of SLE patients with the most common cause being anemia of chronic disease; however, other causes include autoimmune hemolytic anemia, iron deficiency anemia, anemia of chronic renal failure, and cyclophosphamide myelotoxicity. [7] Nonerosive arthritis is seen in patients with SLE. Prolonged glucocorticoid use for immunosuppression could cause osteoporosis. Incidence of atlantoaxial subluxation has been reported. [8]

Antiphospholipid syndrome may occur secondary to SLE and is characterized clinically by recurrent pregnancy loss and by presence of lupus anticoagulant antibodies which may falsely prolong activated partial thromboplastin time in such individuals. [9]

The preoperative visit aims at the activity of the lupus, organ damage, medication exposure, thorough preanesthetic assessment, and laboratory test. Care of the high-risk patients requires a multidisciplinary approach.

As SLE symptoms are nonspecific, the investigations become mainstay in monitoring. Complete blood count has to be done in all patients alongside coagulation profile. Platelet count should be repeated every month because of high risk of thrombocytopenia in lupus patients. [7] Electrocardiography may be done when suspecting pericarditis, myocarditis, and chest X-ray may be reserved for extreme cases where pleural effusion or interstitial pneumonitis is seen clinically. [2] For patients with renal involvement, every month creatinine clearance and 24 h urine protein should be checked. If the patient is on steroids then, a close watch on blood glucose levels is advocated. Anticardiolipin antibody, lupus anticoagulant, anti-β2 glycoprotein should be done to rule out any secondary involvement in succeeding months.

Monitoring during anesthesia includes five-lead ECG, noninvasive blood pressure, pulse oximetry, and invasive monitoring should be used in patients with myocarditis, valvular involvement, or conduction abnormalities. Renal protective strategies and maintenance of urine output, avoidance of nephrotoxic drugs are the goals during anesthesia. Adequate pain management and corticosteroid cover should be given intraoperatively to prevent adrenal suppression. Antibiotics are to be given to prevent infection. Patient should be positioned with care to avoid joint stress.

Difficult airway should be anticipated in all the patients, smaller sized tubes, and laryngeal mask airway must be available considering the potential laryngeal and the subglottic involvement. Laryngeal involvement could vary from mild inflammation to laryngeal edema, epiglottis, and vocal cord paralysis [10] to acute airway obstruction. The pathophysiology of laryngeal inflammation of SLE is not well-understood although the tissue deposition of immune complexes with activation of complements is less likely the cause. Compression of recurrent laryngeal nerve by dilated pulmonary artery has been reported as the cause of left palsy in patients with SLE. Secondary nerve vasculitis is believed to be a cause especially in vocal cord palsy involving right side. [11] There is a significant risk of failed intubation and airway trauma during instrumentation. Pharmacological interactions between anesthetic drugs and immunosuppressant drugs should warrant consideration. Azathioprine, an antimetabolite immunosuppressor, may interact with muscle relaxants, and dose increases of 37% with cisatracurium, 20% with vecuronium, and 45% with pancuronium were required in one-study. [12]

To conclude, with proper understanding of the pathophysiology and systemic organ involvement with SLE, these patients can be managed successfully.

 
  References Top

1.
Ben-Menachem E. Review article: Systemic lupus erythematosus: A review for anesthesiologists. Anesth Analg 2010;111:665-76.  Back to cited text no. 1
[PUBMED]    
2.
Davies SR. Systemic lupus erythematosus and the obstetrical patient - Implications for the anaesthetist. Can J Anaesth 1991;38:790-5.  Back to cited text no. 2
[PUBMED]    
3.
Pandey DP, Pai MV, Kumar P. Systemic lupus erythematosus and pregnancy: Today's scenario. Internet J Gynaecol Obstet 2009;11:2.  Back to cited text no. 3
    
4.
Mintz G, Rodriguez-Alvarez E. Systemic lupus erythematosus. Rheum Dis Clin North Am 1989;15:255-74.  Back to cited text no. 4
    
5.
Kamen DL, Strange C. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 2010;31:479-88.  Back to cited text no. 5
    
6.
Mok CC. Understanding lupus nephritis: Diagnosis, management, and treatment options. Int J Womens Health 2012;4:213-22.  Back to cited text no. 6
[PUBMED]    
7.
Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis 2006;1:6.  Back to cited text no. 7
    
8.
Klemp P, Meyers OL, Keyzer C. Atlanto-axial subluxation in systemic lupus erythematosus: A case report. S Afr Med J 1977;52:331-2.  Back to cited text no. 8
[PUBMED]    
9.
Garg P, Gaba P, Saxena KN, Taneja B. Anesthetic implication of antiphospholipid antibody syndrome in pregnancy. J Obstet Anaesth Crit Care 2011;1:35-7.  Back to cited text no. 9
  Medknow Journal  
10.
Lee JH, Sung IY, Park JH, Roh JL. Recurrent laryngeal neuropathy in a systemic lupus erythematosus (SLE) patient. Am J Phys Med Rehabil 2008;87:68-70.  Back to cited text no. 10
    
11.
Narsimulu G. Bilateral vocal cord palsy as a manifestation of systemic lupus eryhtematosus. Lupus 2009;1:1-2.  Back to cited text no. 11
    
12.
Gramstad L. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. Br J Anaesth 1987;59:995-1003.  Back to cited text no. 12
[PUBMED]    




 

Top
 
Previous article    Next article
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  IN THIS Article
   Abstract
  Introduction
  Case Report
  Discussion
   References

 Article Access Statistics
    Viewed2495    
    Printed24    
    Emailed2    
    PDF Downloaded148    
    Comments [Add]    

Recommend this journal